Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea + Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT00180973Phase 3Unknown
- Sponsor
- Gustave Roussy
- Start
- Feb 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydroxyurea in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Gustave Roussy. Primary endpoint: Overall Survival at 5 years. Status: unknown.
02
Drugs
hydroxyurea
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00180973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180973.